Brief: Akari Therapeutics Provides Updates On Development Of Nomacopan In Pediatric And Adult HSCT-TMA

Akari Therapeutics

13/07/2023 13:58

July 13 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS PROVIDES UPDATES ON DEVELOPMENT OF
NOMACOPAN
IN PEDIATRIC AND ADULT HSCT-TMA
    * AKARI THERAPEUTICS - ON TRACK FOR START OF ENROLLMENT BY
END OF
2023 IN REGISTRATIONAL PHASE 3 STUDY OF NOMACOPAN IN PEDIATRIC
HSCT-TMA
    * AKARI THERAPEUTICS-MOVING FORWARD INTO PHASE 3
DOUBLE-BLIND
PLACEBO-CONTROLLED CLINICAL TRIAL OF NOMACOPAN IN ADULT
HSCT-TMA, TO BEGIN ENROLLMENT IN 2024

Source text for Eikon:  ID:nGNEb0hHL3 
Further company coverage:  AKTX.O